New formulations and use thereof

Details for Australian Patent Application No. 2002334523 (hide)

Owner Pfizer Health AB

Inventors Landh, Tomas; Lindberg, Nils-Olof

Agent Spruson & Ferguson

Pub. Number AU-B-2002334523

PCT Number PCT/SE02/01612

PCT Pub. Number WO2003/026656

Priority 0103210-1 27.09.01 SE

Filing date 10 September 2002

Wipo publication date 7 April 2003

Acceptance publication date 15 February 2007

International Classifications

A61K 47/44 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Oils, fats or waxes according to more than one of groups

A23G 1/00 (2006.01) Cocoa

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/4439 (2006.01)

A61K 31/465 (2006.01) - Nicotine

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/16 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing nitrogen

A61K 47/24 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 25/34 (2006.01) Drugs for disorders of the nervous system

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

Event Publications

13 February 2003 Complete Application Filed

  Priority application(s): 0103210-1 27.09.01 SE

26 June 2003 Application Open to Public Inspection

  Published as AU-B-2002334523

15 February 2007 Application Accepted

  Published as AU-B-2002334523

14 June 2007 Standard Patent Sealed

4 October 2007 Assignment Registered

  Pfizer-Health AB The patent has been assigned to McNeil AB

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002334524-FACIAL MOTION CLONING

2002334522-New formulations and use thereof